SARS Outbreak — March-July 2003
First modern pandemic scare tests global markets
SARS infected over 8,000 people and killed 774 globally. The S&P 500 fell 8-10% from January to mid-March 2003, entangled with the dot-com hangover and Iraq War uncertainty. Once the WHO declared SARS contained on July 5, 2003, the S&P 500 rallied +18.6% over six months and finished the year up over 26%.
What history says
Editorial commentary written by ALAN analysts. Figures cited below are analyst-authored context — they are not derived from the chart above and may reflect different windows or sources.
SARS hit while the market was already deeply oversold from the 2000-2002 bear. Separating the pandemic selloff from the bear market bottom is nearly impossible.
Hong Kong's Hang Seng fell roughly 15% during peak SARS fear. US market impact was muted because domestic economic exposure was minimal.
SARS, Ebola (2014), and Zika (2016) each caused brief volatility but no lasting S&P 500 damage. COVID-19 broke this pattern because of the unprecedented economic shutdown, not the virus itself.
Health scares before COVID followed a consistent arc — regional equity pain, brief global volatility, recovery on containment. Rather than de-risking on outbreak headlines, consider reviewing which holdings carry genuine revenue exposure to the affected region, and let containment milestones rather than case counts mark the fundamental turn.